Following people with keratoconus over time to learn how it progresses
Follows people with keratoconus to study risk factors, progression and vision care.
Key facts
- Who runs it
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Clinical and Subclinical Keratoconus Cohort Study
- Status
- Not yet recruiting
- People taking part
- 421 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 1 Dec 2029
- Type of study
- Observational
- Record updated
- 28 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with keratoconus, a disease where the clear front of the eye (cornea) thins and bulges. People with suspected or early keratoconus without symptoms can also join. The study follows them over time.
- Age
- 4 years or older. Under 18, a parent or guardian must also give written consent.
- Sex
- All sexes
- Disease stage
- Three groups. Suspected keratoconus: neither eye meets the diagnosis, vision BCVA≥1.0, no clear signs on slit-lamp exam, at least one abnormal corneal map feature, and 1.6≤BAD-D < 2.6 on Pentacam. Subclinical: the other eye has keratoconus, the included eye has BCVA≥1.0, no clear slit-lamp signs and BAD-D < 2.6. Keratoconus: history of short-sightedness and astigmatism, BCVA≤1.0, at least one slit-lamp sign, abnormal corneal map and BAD-D≥2.6.
- Earlier treatment
- People who had eye surgery before cannot join.
- Biomarker or test result
- Corneal scan results: BAD-D value on Pantacam, and corneal map values such as KISA>60%, I-S >1.4D, Km>47.2D or PTE>11μm for suspected cases.
Main reasons for not taking part
- Past eye surgery and marked scarring of the cornea
- Unable to understand or cooperate with exams and follow-up
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Inclusion criteria for suspected keratoconus 1.1 Both eyes did not meet the diagnostic criteria for keratoconus, and the included eyes met the criteria 1.1.1 BCVA≥1.0 1.1.2 No obvious abnormal signs under slit lamp; 1.1.3 At least one abnormal corneal topography feature: abnormal anterior corneal surface (KISA>60%); Asymmetric collar with or without meridional tilt (I-S >1.4D); Abnormal increase of corneal curvature (Km>47.2D); The posterior surface of the cornea was abnormally elevated (PTE>11μm); 1.1.4 1.6≤BAD-D < 2.6 in Pantacam. 1.2 Patients aged 4 years or older. 1.3 informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent
- Inclusion criteria for subclinical keratoconus:; 2.1 The contralateral eye was diagnosed with keratoconus, and the included eye met the following criteria: 2.1.1 BCVA≥1.0 2.1.2 No obvious abnormal signs under slit lamp; 2.1.3 BAD-D < 2.6 in Pantacam. 2.2 Age ≥ 4 years old. 2.3 informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent
- Keratoconus inclusion criteria:; 3.1 History of myopia and astigmatism, BCVA≤1.0 3.2 Slit-lamp examination reveals at least one sign: corneal thinning, conical protrusion, Vogts striae, Fleischers rings, or anterior stromal scarring; 3.3 abnormal corneal topography features, such as asymmetric bow tie, subtemporal steeping, abnormal thickness distribution, and reduced minimum thickness, with BAD-D≥2.6 in Pantacam; 3.4 Age ≥ 4 years old. 3.5 Informed consent was obtained from patients. If the patient was younger than 18 years of age, the patient and guardian provided written informed consent
Who cannot take part
- Patients with a history of ocular surgery and significant corneal scarring
- Patients who could not understand or cooperate with the examination and follow-up
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The pathogenesis of keratoconus remains unclear, and its natural course has yet to be fully understood. For non-progressive patients and post-surgical cases, clinical management primarily involves follow-up observation, with significant challenges in visual rehabilitation. This study aims to establish a prospective keratoconus cohort to identify risk factors, natural progression, and the efficacy of interventions. Additionally, it seeks to explore changes in ocular biometric parameters and other pathophysiological characteristics in keratoconus patients, investigate the relationship between keratoconus and systemic diseases or comorbidities, and assess refractive interventions and visual rehabilitation strategies for keratoconus patients.
The group in the trial
- keratoconus
keratoconus patient
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical and Subclinical Keratoconus Cohort Study
- Plain-language title
- Following people with keratoconus over time to learn how it progressesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 28 April 2026